Physician

David J Neidhardt, MD

According to 2025 Medicare claims, David Neidhardt, MD (NPI: 1396797510) practices emergency medicine in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is WEST MARKET STREET FAMILY PHYS (NPI: 1225159791; TIN: 341502616) and primary practice location at 45805-2769. Neidhardt is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Neidhardt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 482 traditional Medicare patients, billed 2,758 HCPCS/CPT codes, and received $128,595 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 7,360 prescription claims across 649 beneficiaries totaling $765,374 in drug costs, led by Jardiance (Empagliflozin). DME data shows 26 claims. Open Payments data shows 69 records totaling $34,023. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and declined steadily, from $16,906 to $5,127.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	560	3,703	$137,582
2016	609	3,671	$125,584
2017	677	3,956	$148,755
2018	700	4,065	$172,722
2019	632	3,970	$160,296
2020	560	2,656	$131,961
2021	565	3,040	$133,774
2022	529	2,752	$87,791
2023	504	2,800	$102,860
2024	482	2,758	$128,595

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	693	10,072	$802,401
2016	643	9,722	$740,663
2017	743	9,368	$669,384
2018	843	9,608	$694,982
2019	786	8,657	$682,033
2020	655	7,914	$705,019
2021	724	7,633	$728,967
2022	686	7,463	$730,542
2023	688	7,812	$806,669
2024	649	7,360	$765,374

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	97	473	$16,792
2016	106	474	$13,730
2017	61	294	$7,188
2018	77	366	$10,320
2019	95	562	$14,809
2020	30	260	$6,020
2021	35	233	$8,015
2022	19	105	$7,255
2023	19	113	$9,193
2024	11	26	$372

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	188	188	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	115	158	$83
99221	Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes	187	201	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	257	491	$54
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	188	954	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	111	6,282	$122,170
Mounjaro	Tirzepatide	76	2,466	$88,346
Trulicity	Dulaglutide	54	2,352	$75,080
Ozempic	Semaglutide	58	2,324	$72,696
Eliquis	Apixaban	119	3,667	$71,188

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	26	$372

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$34,023	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David J. Neidhardt, MD?

Tedicare shows public-source Medicare data for David J. Neidhardt, MD (NPI 1396797510), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David J. Neidhardt, MD have ACO affiliation data?

David J. Neidhardt, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to David J. Neidhardt, MD?

David J. Neidhardt, MD is linked to WEST MARKET STREET FAMILY PHYS (billing NPI 1225159791) in the available physician profile data.

Does David J. Neidhardt, MD have Open Payments data?

David J. Neidhardt, MD has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.